Washington, DCA popular collection of medications that parents have relied upon for years to treat the aches and pains of childhood are being recalled due to drug manufacturing deficiencies, according to a recent statement by the US Food and Drug Administration (FDA), augmenting a voluntary recall issued April 30th by the McNeil Consumer Healthcare division of Johnson & Johnson.
While the manufacturer stopped short of suggesting the products were unsafe, there are deficiencies that could affect the purity or quality of the products. To that end, there is a concern that some of the products may contain too much of the active ingredient, which could prove an issue for certain children with higher sensitivities to medication.
The recalled products have been identified as certain lots of children's and infant's Tylenol, Motrin, Zyrtec and Benadryl. The products are sold over-the-counter (OTC) and are in liquid form.
The recalled list include lots of Tylenol Infants' Drops, Children's Tylenol Suspensions, Infants' Motrin Drops, Children's Zyrtec liquid in bottles and Children's Benadryl Allergy liquids in bottles. The FDA said in the May 1st statement that beyond the concern over the potential for quality, purity and potency is the potential for some of the products to contain tiny particles or inactive ingredients that may have failed to meet testing protocols.
McNeil said that while the potential for serious health issues or medical problems is remote, parents and caregivers are advised to avoid giving the products to children—and to stop using them immediately.
A complete list of products and lot numbers can be found here.